Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 23, 2025 08:00 ET | Source: Vanderbilt Report and Coeptis Therapeutics

Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating

Coeptis Therapeutics (NASDAQ: COEP) is pioneering a dual-track model designed to sustain innovation while reducing reliance on dilutive funding.